Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 11Terminated 3Withdrawn 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Multiple Myeloma 2Breast Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pain 1Osteoporosis 1Osteonecrosis 1Neoplasms, Plasma Cell 1Neoplasms 1Neoplasm Metastasis 1Humoral Hypercalcemia Of Malignancy 1

Interventions

Water 3Psychiatric Rehabilitation 3Colonoscopy 3Analgesia 3Therapeutics 2Radiotherapy 2Ibandronic Acid 2resiniferatoxin 1Zoledronic Acid 1Transcranial Direct Current Stimulation 1Surveys and Questionnaires 1Sufentanil 1Standard of Care 1Radiation 1Quality of Life 1Psilocybin 1Palliative Care 1Pain Management 1Olanzapine 1Nutritional Support 1Nicotine 1Lidocaine 1Interviews as Topic 1Genistein 1Fentanyl 1Cryotherapy 1Cryosurgery 1Celecoxib 1Botulinum Toxins, Type A 1Acupuncture Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Pain × Zoledronic Acid × Clear all
NCT00301886 2013-11-13

S0308 Zoledronate or Ibandronate in Preventing Bone Problems in Women With Stage IV Breast Cancer That Has Spread to the Bone

SWOG Cancer Research Network

Phase 3 Withdrawn
Breast

Humoral Hypercalcemia Of Malignancy, Breast Neoplasms, Neoplasm Metastasis, Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡